Halaven
Term · Oncology and biomedicine · MLC-T-ONC-003712
A drug used to treat certain types of breast cancer and liposarcoma (a type of soft tissue sarcoma) that have already been treated with other anticancer drugs. It is also being studied in the treatment of other types of cancer. Halaven blocks cell growth by stopping cell division and may kill cancer cells. It is a type of antimicrotubule agent. Also called E7389 and eribulin mesylate.
| Identifier | MLC-T-ONC-003712 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | E7389; eribulin mesylate |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-003712",
"term": "Halaven",
"field": "Oncology and biomedicine",
"definition": "A drug used to treat certain types of breast cancer and liposarcoma (a type of soft tissue sarcoma) that have already been treated with other anticancer drugs. It is also being studied in the treatment of other types of cancer. Halaven blocks cell growth by stopping cell division and may kill cancer cells. It is a type of antimicrotubule agent. Also called E7389 and eribulin mesylate.",
"synonyms": [
"E7389",
"eribulin mesylate"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/halaven/"
}
Record 8,258 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.